Full Text
COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS

Abstract

Authors

A Miquel-Cases L Steuten L Rigter WH van Harten

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×